600+ sources. One page. See who else covered it.
UK fibrosis biotech Redx Pharma is making another go at a reverse merger, after its last attempt was axed in 2023. The ROCK inhibitor developer will take the Nasdaq listing of Skye ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Abcuro has collected $66 million a few months after saying its sole drug missed the mark in a muscle-weakening condition but had found hope in a subset of patients with less severe forms. CEO Alex ...
The International Council of Nurses says some nurses and other health workers have gone unpaid for two to three months while facing serious risks to their lives.
The International Council of Nurses says some nurses and other health workers have gone unpaid for two to three months while facing serious risks to their lives.
After a negative FDA advisory committee vote, Capricor Therapeutics said it will file additional data and analyses on its Duchenne muscular dystrophy therapy in hopes of a better shot at potential…
The FDA classified a recall of 1.5 million eggs as Class I due to Salmonella risks. Midwest Poultry Services initiated the recall.
A fully licensed Nigerian pharmaceutical manufacturing company has changed ownership after its 84-year-old founder sold a majority stake to a group of young Nigerian entrepreneurs, in a deal brokered…